Development of orally active oxytocin antagonists: studies on 1-(1-{4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl) piperidin-4-yloxy]-2-methoxybenzoyl} piperidin-4-yl)-1, 4- …
IM Bell, JM Erb, RM Freidinger…
文献索引：Journal of Medicinal Chemistry, , vol. 41, # 12 p. 2146 - 2163
... Journal of Medicinal ... Departments of Drug Metabolism, Medicinal Chemistry, Pharmacology, and Process Research, Merck Research Laboratories, West Point, Pennsylvania 19486 ... for preterm babies is extremely expensive, and they often incur additional medical costs resulting ...
